StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
OMEROMEROS CORP
stockpulse.co.kr
Nasdaq
$16.76▲ 1.27%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.21BShares out 72.4M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

22
  • 9.25Overnight26.09.25 10:00
    4Ownership#●●●

    OMEROS CORP

    Insider David J. Borges of Omeros Corp filed a Form 4 report regarding changes in beneficial ownership of securities as of September 22, 2026. This filing serves as the official disclosure of the insider's equity transaction.…more

    $16.76+1.27%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.23After-hours26.09.24 05:20
    144Ownership

    OMEROS CORP

    Omeros Corp insider David J. Borges has filed an SEC Form 144 to report a proposed sale of company shares. This filing serves as a formal notification of the insider's plan to dispose of their equity holdings.…more

    $16.76+1.27%vs prev close
    View filingShare
  • 9.22After-hours26.09.23 05:15
    144Ownership

    OMEROS CORP

    Omeros Corp insider David J. Borges has filed an SEC Form 144 to report a proposed sale of company stock. This filing serves as a standard notification of an insider's plan to dispose of shares.…more

    $16.76+1.27%vs prev close
    View filingShare

21 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 10.16Pre-market26.10.16 19:22
    Bullish#●●●#●●●

    Omeros Receives Negative Opinion from EMA for Narsoplimab

    Omeros' drug Narsoplimab has received a final negative opinion from the European Medicines Agency (EMA). Despite its approval in the U.S., the rejection in Europe hinders the company's expansion plans in the region.…more

    $16.76+1.27%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.22Pre-market26.09.22 21:20

    ●●●●●●●● ●●●●● ●●●●●●

    Major Wall Street analysts, including those from Piper Sandler and Keybanc, have upgraded their ratings for five companies such as MetLife and Plexus. These adjustments reflect positive outlooks and increased price targets for the affected stocks.…more

    $16.76+1.27%vs prev close
    ShareBenzinga

1 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →